Phenylphosphines and derivatives
Strem, An Ascensus Company CAS# 63995-75-5. 1g. Diphenyl(m-sulfonatophenyl)phosphine dihydrate sodium salt, min. 90%. MFCD07772021
CAS# 63995-75-5. 1g. Diphenyl(m-sulfonatophenyl)phosphine dihydrate sodium salt, min. 90%. MFCD07772021. Molecular Weight: 364.33 (400.36). Molecular Formula: (C6H5)2P(C6H4SO3Na)∙2H2O. Color/form: white pwdr. Strem# 15-1827. http://www.strem.com/catalog/v/15-1827/
Aobchem 1-Fluoro-2-(methoxymethyl)-4-methylbenzene | 97% | CAS 2901099-95-2 | C9H11FO | 500mg
1-Fluoro-2-(methoxymethyl)-4-methylbenzene | 97% | CAS 2901099-95-2 | C9H11FO | 500mg
Aobchem 1-Bromo-2-(methoxymethyl)-4-(trifluoromethyl)benzene | ≥95% | CAS 1646161-42-3 | C9H8BrF3O | 5g
1-Bromo-2-(methoxymethyl)-4-(trifluoromethyl)benzene | ≥95% | CAS 1646161-42-3 | C9H8BrF3O | 5g
Aobchem 6-Bromo-3-(methoxymethyl)-2-methylpyridine | 97% | CAS 2921905-25-9 | C8H10BrNO | 5g
6-Bromo-3-(methoxymethyl)-2-methylpyridine | 97% | CAS 2921905-25-9 | C8H10BrNO | 5g
Aobchem 6-Bromo-3-(methoxymethyl)-2-methylpyridine | 97% | CAS 2921905-25-9 | C8H10BrNO | 250mg
6-Bromo-3-(methoxymethyl)-2-methylpyridine | 97% | CAS 2921905-25-9 | C8H10BrNO | 250mg
Aobchem Methyl 2-(methoxymethyl)-5-methylbenzoate | 95% | CAS 2117628-96-1 | C11H14O3 | 250mg
Methyl 2-(methoxymethyl)-5-methylbenzoate | 95% | CAS 2117628-96-1 | C11H14O3 | 250mg
Medchemexpress LLC Tetrakis(triphenylphosphine)platinum(0) | 14221-02-4 | MFCD00010014 | 98.2% | 1244.22 g·mol⁻¹ | C72H60P4Pt | 500 MG
Tetrakis(triphenylphosphine)platinum is a platinum(0) coordination complex used as a reagent and precursor to platinum complexes in organometallic and organic synthesis. Supplied as a light yellow solid, it is typically handled under inert atmosphere and protected from light for storage and use in research.
- Coordination complex used as a platinum(0) reagent.
- Light yellow solid; handle under inert gas and protect from light.
- High purity suitable for research and synthetic applications.
- Molecular formula C72H60P4Pt; molecular weight 1244.22 g·mol⁻¹.
- Available in small laboratory pack sizes for bench-scale work.
Medchemexpress LLC Tetrakis(acetonitrile)palladium(II) tetrafluoroborate | 21797-13-7 | MFCD00043297 | >98.0% | 444.22 g/mol | C8H12B2F8N4Pd | 100 MG
Tetrakis(acetonitrile)palladium(II) tetrafluoroborate is a palladium(II) complex provided as a solid reagent for laboratory research. It functions as a soluble Pd(II) source for homogeneous catalysis and organometallic synthesis, commonly used in cross-coupling reactions where a well-defined palladium species is required. The reagent is supplied with high purity and appropriate small-scale packaging for experimental work.
- Soluble Pd(II) source in acetonitrile for homogeneous catalysis.
- High purity suitable for research applications.
- Stable solid reagent with light yellow to brown appearance.
- Convenient small-scale packaging for laboratory use.
- Useful in cross-coupling and organometallic synthesis.
Cambridge Isotope Laboratories (METHOXYMETHYL)TRIPHENYLPHOSPHONIUM CHLORIDE (METHYL-13C, 99%), 1 G
(METHOXYMETHYL)TRIPHENYLPHOSPHONIUM CHLORIDE (METHYL-13C, 99%), 1 G
eMolecules 220556-03-6 | ChemScene | 4-(2-Bromoethyl)benzene-12-diol | 250mg | 625603951 | CS-0179651 | MFCD18804789 | 217.062 | C8H9BrO2
Ambeed | 3-(4455-Tetramethyl-132-dioxaborolan-2-yl)benzenesulfonamide | 250mg | 660583546 | A186085 | 486422-08-6 | MFCD07781217 | 283.150 | C12H18BNO4S
If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool
Medchemexpress LLC Deoxyelephantopin | 29307-03-7 | 1 MG
Deoxyelephantopin is a natural bioactive sesquiterpene lactone derived from Elephantopus scaber. It exhibits promising anticancer effects against a wide range of cancers, functioning by inhibiting NF-κB, MAPK, PI3K/Akt, and β-catenin signaling pathways. It is for research use only.
- Inhibits NF-κB, MAPK, PI3K/Akt, and β-catenin signaling pathways.
- Demonstrates anticancer effects against various cancer cell lines including colorectal, chronic myeloid leukemia, oral, and breast.
- Increases expression of p53, p-JNK, and p-p38 in cancer cells.
- Decreases expression of p-STAT3 and p-mTOR in cancer cells.
- Downregulates MMP-2, MMP-9, uPA, and uPAR mRNA levels in cancer cells.